Literature DB >> 15572270

Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures.

Krzysztof Labuzek1, Jan Kowalski, Bozena Gabryel, Zbigniew S Herman.   

Abstract

The cytokines IL-1beta and IL-2 are released from activated glial cells in the central nervous system and they are able to enhance catecholaminergic neurotransmission. There is no data concerning influence of antipsychotics on glial cell activity. Antipsychotics reaching the brain act not only on neurons but probably also on glial cells. The aim of this study was to evaluate the effect of chlorpromazine and loxapine on release of IL-1beta and IL-2 by mixed glial and microglial cell cultures. Chlorpromazine in concentrations 2 and 20 muM, and loxapine 0.2, 2 and 20 microM reduced IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Chlorpromazine in concentrations of 0.2, 2 and 20 microM reduced the IL-2 secretion in mixed glial cultures after 3 days of exposure. Loxapine in concentrations of 0.2, 2 and 20 microM reduced IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally loxapine decreased IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2, 10 and 20 muM. Quinpirole-a D2 dopaminergic agonist increased LPS-induced IL-1beta and IL-2 secretion in mixed glia cultures only in the highest dose of 20 microM. These findings suggest the absence of functional dopamine receptors on cortical microglial cells. Mixed glia cultures deprived of microglia (by shaking and incubating with L-leucine methyl ester) did not release IL-1beta and IL-2. This observation suggests that microglia can be a source of assessed cytokines. Results of the present study support the view that antipsychotics act not only on neurons but also on glial cells. However, the clinical significance of these observations still remains unclear.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15572270     DOI: 10.1016/j.euroneuro.2004.04.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  15 in total

Review 1.  Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.

Authors:  Joana Prata; Susana G Santos; Maria Inês Almeida; Rui Coelho; Mário A Barbosa
Journal:  J Neuroinflammation       Date:  2017-09-04       Impact factor: 8.322

2.  Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.

Authors:  Luokun Xie; Gourav Roy Choudhury; Ali Winters; Shao-Hua Yang; Kunlin Jin
Journal:  Eur J Immunol       Date:  2014-11-24       Impact factor: 5.532

3.  Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes.

Authors:  Iwona Karwaciak; Kaja Karaś; Anna Sałkowska; Joanna Pastwińska; Marcin Ratajewski
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

4.  Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1 beta levels in the rat brain.

Authors:  Ewa Obuchowicz; Agnieszka Marcinowska; Lukasz Drzyzga; Jacek Wójcikowski; Władysława A Daniel; Zbigniew S Herman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-01       Impact factor: 3.000

5.  Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia.

Authors:  Krzysztof Labuzek; Sebastian Liber; Bozena Gabryel; Jakub Adamczyk; Bogusław Okopień
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-11       Impact factor: 3.000

6.  Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures.

Authors:  Krzysztof Labuzek; Sebastian Liber; Bozena Gabryel; Lukasz Bułdak; Bogusław Okopień
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-26       Impact factor: 3.000

7.  Comparative analysis of the expression of c-Fos and interleukin-2 proteins in hypothalamus cells during various treatments.

Authors:  S V Barabanova; Z E Artyukhina; K T Ovchinnikova; T V Abramova; T B Kazakova; V Kh Khavinson; V V Malinin; E A Korneva
Journal:  Neurosci Behav Physiol       Date:  2008-03

Review 8.  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Authors:  Edward C Lauterbach
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

9.  Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells.

Authors:  Valentino Racki; Marina Marcelic; Igor Stimac; Daniela Petric; Natalia Kucic
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

10.  Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy.

Authors:  Fuyan Xu; Huizhi Xi; Mengya Liao; Yiqian Zhang; Hongbo Ma; Mengling Wu; Qiang Xue; Hongbao Sun; Yiwen Zhang; Yong Xia
Journal:  Cancer Chemother Pharmacol       Date:  2022-01-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.